Menu
GeneBe

SLC39A4

solute carrier family 39 member 4, the group of Solute carrier family 39

Basic information

Region (hg38): 8:144409741-144416844

Previous symbols: [ "AEZ" ]

Links

ENSG00000147804NCBI:55630OMIM:607059HGNC:17129Uniprot:Q6P5W5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • acrodermatitis enteropathica (Strong), mode of inheritance: AR
  • acrodermatitis enteropathica (Strong), mode of inheritance: AR
  • acrodermatitis enteropathica (Strong), mode of inheritance: AR
  • acrodermatitis enteropathica (Supportive), mode of inheritance: AR
  • acrodermatitis enteropathica (Definitive), mode of inheritance: AR
  • acrodermatitis enteropathica (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Acrodermatitis enteropathica, zinc-deficiency typeARBiochemicalThe condition may present with failure to thrive, diarrhea, and dermatitis, and, if untreated, may evolve to include other sequelae of zinc deficiency, including immunodeficiency and neurologic manifestations, and medical management (eg, treatment with oral zinc therapy) can be effectiveBiochemical; Dermatologic; Gastrointestinal4136854; 1090826; 12068297; 19370757; 20883266; 21165302; 21762381; 21906148; 21907902; 22082465; 22166942; 23228939; 23430849
Heterozygous variants have been reported as disease-associated in some reports

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC39A4 gene.

  • not provided (624 variants)
  • Hereditary acrodermatitis enteropathica (145 variants)
  • Inborn genetic diseases (49 variants)
  • not specified (6 variants)
  • SLC39A4-related condition (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC39A4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
357
clinvar
8
clinvar
367
missense
1
clinvar
4
clinvar
69
clinvar
14
clinvar
6
clinvar
94
nonsense
11
clinvar
1
clinvar
1
clinvar
13
start loss
0
frameshift
34
clinvar
4
clinvar
2
clinvar
40
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
22
clinvar
23
splice region
3
52
8
63
non coding
1
clinvar
5
clinvar
55
clinvar
13
clinvar
74
Total 48 31 79 426 27

Highest pathogenic variant AF is 0.000394

Variants in SLC39A4

This is a list of pathogenic ClinVar variants found in the SLC39A4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-144412477-T-C Hereditary acrodermatitis enteropathica Uncertain significance (Jan 13, 2018)911884
8-144412510-G-A Hereditary acrodermatitis enteropathica Uncertain significance (Jan 13, 2018)911885
8-144412545-G-A Hereditary acrodermatitis enteropathica Uncertain significance (Sep 04, 2020)990598
8-144412547-G-A Likely benign (May 28, 2023)2959476
8-144412550-G-A Likely benign (May 11, 2023)1652719
8-144412558-C-T Hereditary acrodermatitis enteropathica Uncertain significance (Jan 12, 2018)911886
8-144412559-G-A Likely benign (Nov 14, 2021)1669279
8-144412564-G-A Likely benign (Sep 21, 2023)1099776
8-144412571-C-A Likely benign (Sep 09, 2020)1160987
8-144412573-G-A Likely benign (Dec 06, 2023)1124398
8-144412576-G-A Likely benign (Feb 05, 2023)2832375
8-144412577-C-A Likely benign (Jan 04, 2024)1656128
8-144412579-G-A Hereditary acrodermatitis enteropathica Likely benign (Jan 29, 2024)765489
8-144412583-G-A Likely benign (Oct 07, 2022)1585825
8-144412584-G-A Uncertain significance (Jul 10, 2019)1306655
8-144412586-C-T Uncertain significance (Mar 07, 2018)429357
8-144412589-G-A Likely benign (Jun 06, 2023)1558472
8-144412589-G-C Likely benign (Jan 14, 2024)1140381
8-144412592-G-A Likely benign (Apr 15, 2023)1133263
8-144412594-C-G Hereditary acrodermatitis enteropathica Likely pathogenic (Jan 30, 2023)2433455
8-144412598-C-A Likely benign (Jul 17, 2020)1125461
8-144412598-C-G Likely benign (Dec 09, 2019)1100524
8-144412598-C-T Likely benign (Sep 16, 2021)1583459
8-144412600-G-A Likely benign (Feb 08, 2023)2872266
8-144412607-G-A Likely benign (Oct 22, 2023)2794229

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC39A4protein_codingprotein_codingENST00000301305 127154
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0003140.9971256620261256880.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2954123951.040.00002694018
Missense in Polyphen100119.410.837481366
Synonymous-3.752732051.330.00001691417
Loss of Function2.661024.10.4150.00000105262

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.0001220.000109
Finnish0.00005540.0000462
European (Non-Finnish)0.0002230.000185
Middle Eastern0.0001220.000109
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in cellular zinc homeostasis as a zinc transporter. Regulated in response to zinc availability (By similarity). {ECO:0000250}.;
Pathway
Mineral absorption - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Zinc homeostasis;Senescence and Autophagy in Cancer;Zinc influx into cells by the SLC39 gene family;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Metal ion SLC transporters;Zinc transporters (Consensus)

Recessive Scores

pRec
0.127

Intolerance Scores

loftool
0.530
rvis_EVS
1.21
rvis_percentile_EVS
93.05

Haploinsufficiency Scores

pHI
0.0991
hipred
N
hipred_score
0.172
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.231

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Slc39a4
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
cellular zinc ion homeostasis;signal transduction;cellular response to zinc ion starvation;zinc ion import across plasma membrane
Cellular component
plasma membrane;integral component of plasma membrane;apical plasma membrane;cytoplasmic vesicle;recycling endosome membrane
Molecular function
zinc ion transmembrane transporter activity